Klarquist Sparkman, LLP
Human monoclonal antibodies specific for glypican-3 and use thereof
Described herein is the identification of human monoclonal antibodies that bind GPC3 or heparan sulfate (HS) chains on GPC3 with high affinity. The antibodies described herein are capable of inhibiting HCC cell growth and migration. Provided are human monoclonal antibodies specific for GPC3 or HS chains on GPC3, including immunoglobulin molecules, such as IgG antibodies, as well as antibody fragments, such as single-domain VH antibodies or single chain variable fragments (scFv). Further provided are compositions including the antibodies that bind GPC3 or HS chains on GPC3, nucleic acid molecules encoding these antibodies, expression vectors comprising the nucleic acids, and isolated host cells that express the nucleic acids. Methods of treating cancer and/or inhibiting tumor growth or metastasis are also provided. Further provided are methods of detecting cancer in a subject and confirming a diagnosis of cancer in a subject.
The United States of America, as represented by the Secretary, Department of Health and Human Services
A A C C A G C G C C C C G A C C C A C C A C C C C C G A G C A
A61K A61K C07K C07K A61K G01N C07K G01N C07K C07K C07K C07K G01N A61K C07K C07K C07K A61K C07K C07K A61K C07K C07K C07K C07K C07K G01N A61P G01N C07K A61K
inventional inventional inventional additional inventional inventional additional inventional additional additional inventional additional additional additional additional additional additional inventional additional additional inventional inventional inventional inventional additional additional additional inventional inventional additional inventional
Mingqian Dimiter S. Mitchell
Feng Dimitrov Ho